| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/28/2013 | CN103263442A Blaps rynchopetera fairmaire extract, as well as preparation method and pharmaceutical use thereof |
| 08/28/2013 | CN103263408A Allicin nano liposome and preparation method and application thereof |
| 08/28/2013 | CN103263402A Water-drinking-free oral drug composition and preparation method thereof |
| 08/28/2013 | CN103263384A Edaravone composition injection and preparation method thereof |
| 08/28/2013 | CN103262797A Space-induced efficient cordyceps militaris and application thereof as well as preparation method of capsule preparation of space-induced efficient cordyceps militaris |
| 08/28/2013 | CN102872051B Application of gypensapogenin A to antidepressant drugs |
| 08/28/2013 | CN102813792B Preparation method of traditional Chinese medicine for treating phlegm-fire confusing heart type insomnia |
| 08/28/2013 | CN102784373B Method for preparing traditional Chinese medicine for treating insomnia caused by malnutrition |
| 08/28/2013 | CN102784356B Method for preparing traditional Chinese medicine for treating insomnia caused by pain |
| 08/28/2013 | CN102784149B 5-aryl-9-alkyl-4,6-dioxo-1-aza-bicyclo[3.3.1]nonane and application of salt thereof |
| 08/28/2013 | CN102743699B Traditional Chinese medicine for treating mental diseases |
| 08/28/2013 | CN102698139B Dangshen Chinese medicinal preparation for treating hypersomnia and preparation method thereof |
| 08/28/2013 | CN102698041B Traditional Chinese medicine compound gel for externally treating cancer pain and preparation method for same |
| 08/28/2013 | CN102697846B Yufengningxin coated dripping pill and preparation method thereof |
| 08/28/2013 | CN102579816B Brain-invigorating tablets and preparation method thereof |
| 08/28/2013 | CN102579715B Chinese medicinal composition for treating hydrocephalus and preparation method thereof |
| 08/28/2013 | CN102579618B Yansheng pills |
| 08/28/2013 | CN102552671B Medicament for curing neurasthenia |
| 08/28/2013 | CN102526279B Chinese medicinal composition for treating central high fever caused by acute cerebrovascular disease and preparation method for Chinese medicinal composition |
| 08/28/2013 | CN102488720B Preparation method for submicron pine needle powder at normal temperature and special bidirectional air-flow screening machine |
| 08/28/2013 | CN102488684B Application of sumatriptan in preparation of medicines for preventing and treating narcomania |
| 08/28/2013 | CN102470123B Pharmaceutical composition containing dopamine receptor agonist |
| 08/28/2013 | CN102430011B Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
| 08/28/2013 | CN102406626B Pramipexole hydrochloride slow release tablet and preparation method thereof |
| 08/28/2013 | CN102389430B Application of small molecular compounds to preparation of anti-lung-cancer medicine |
| 08/28/2013 | CN102293976B Lingxiang herbal pillow |
| 08/28/2013 | CN102260266B Pyrazolo[3,4-d]pyrimidone compounds and application thereof in preparation of phosphodiesterase IX inhibitor |
| 08/28/2013 | CN102123986B Pharmaceutical compositions |
| 08/28/2013 | CN101970458B Novel gamma-secretase inhibitor |
| 08/28/2013 | CN101914031B Pregabalin derivative and application thereof |
| 08/28/2013 | CN101850001B Pharmaceutical composition with function of improving sleep and preparation method thereof |
| 08/28/2013 | CN101820884B Phenothiazine compounds for treating mild cognitive impairment |
| 08/28/2013 | CN101423492B Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 08/27/2013 | US8519183 Uses for amino acid anticonvulsants |
| 08/27/2013 | US8519137 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518995 Methods and compositions for the treatment of irritable bowel syndrome |
| 08/27/2013 | US8518967 Amides of acetic and propionic acids |
| 08/27/2013 | US8518950 2-amido pyrazines for inflammation and immune related uses |
| 08/27/2013 | US8518933 Modulators of 5-HT receptors and methods of use thereof |
| 08/27/2013 | US8518694 Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV |
| 08/27/2013 | US8518443 Opioid agonist formulations with releasable and sequestered antagonist |
| 08/27/2013 | US8518442 Prolonged release bioadhesive therapeutic systems |
| 08/27/2013 | CA2731215C Imidazole carboxamide derivatives and their use in treatment of conditions associated with the mglur2 receptor |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/27/2013 | CA2603939C Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 08/27/2013 | CA2566210C Oxo-substituted cyclohexyl-1,4-diamine derivatives |
| 08/27/2013 | CA2407847C Transgenic animal model of neurodegenerative disorders |
| 08/22/2013 | WO2013123083A1 Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine |
| 08/22/2013 | WO2013122778A1 Methods of treating and preventing diseases and disorders of the central nervous system |
| 08/22/2013 | WO2013121440A1 Process for preparing benzisothiazol-3-yl-peperazin-l-yl-methyl-cyclo hexyl-methanisoindol-1,3-dione and its intermediates |
| 08/22/2013 | WO2013120980A1 Tricyclic compounds and methods of use therefor |
| 08/22/2013 | WO2013120896A1 Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (pde4) |
| 08/22/2013 | WO2013120835A1 Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 08/22/2013 | WO2013120229A1 METHOD FOR PREPARING AQUEOUS MANO PARTICLE SUSPENSIONS OF DERIVATIVES OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURAN ALIPHATIC ACID ESTERS |
| 08/22/2013 | WO2013101911A3 Benzimidazole derivatives as selective blockers of persistent sodium current |
| 08/22/2013 | WO2013100717A3 Composition for preventing and treating multiple sclerosis and autoimmune diseases, containing phellinus igniarius extract |
| 08/22/2013 | WO2013081420A3 Phenoxypropanol derivative and pharmaceutical composition containing same |
| 08/22/2013 | WO2013057222A3 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
| 08/22/2013 | US20130217776 Combination of a Serotonin Reuptake Inhibitor and Agomelatine |
| 08/22/2013 | US20130217723 Pharmaceutical Composition Combining Tenatoprazole and an Anti-Inflammatory Agent |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130217694 Method of reducing the severity of inflammatory dermatological conditions |
| 08/22/2013 | US20130217676 5ht2c receptor modulators |
| 08/22/2013 | US20130217673 Mixed monoamine reuptake inhibitor in a biodegradable polymer carrier |
| 08/22/2013 | US20130216496 Methods for treating tweak-related conditions |
| 08/21/2013 | EP2628754A1 Method for producing and using a copolymer of sodium carboxymethyl cellulose and gossypol |
| 08/21/2013 | EP2628746A2 A process for concentration of a polypeptide |
| 08/21/2013 | EP2628737A1 Hypocholesterolemic, anti-inflammatory and antiepileptic neuroprotective compound |
| 08/21/2013 | EP2628733A1 Acylbenzene derivative |
| 08/21/2013 | EP2627668A1 Peptides and uses |
| 08/21/2013 | EP2627655A2 Therapeutic 5,6,5-tricyclic analogs |
| 08/21/2013 | EP2627652A2 Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof |
| 08/21/2013 | EP2627639A1 N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides |
| 08/21/2013 | EP2627350A1 Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders |
| 08/21/2013 | EP2627330A2 Novel omega-3 and omega-6 fatty acid compositions and uses thereof |
| 08/21/2013 | EP2627329A1 Trpa1 receptor antagonist |
| 08/21/2013 | EP2627328A1 Combinations of serotonin receptor agonists for treatment of movement disorders |
| 08/21/2013 | EP2627326A2 Novel omega-3 and omega-6 fatty acid compositions and uses thereof |
| 08/21/2013 | EP2627192A2 Hydrolysates of animal proteins of marine origin with neuroprotective properties |
| 08/21/2013 | CN203138934U Magnetic health-care mattress for treating osphyalgia, leg pain and bedsore |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
| 08/21/2013 | CN103261203A 6-amido derivatives of 4,5a-poxymorphinans for treatment of pain |
| 08/21/2013 | CN103261202A Fused tricyclic compounds as adenosine receptor antagonist |
| 08/21/2013 | CN103261199A Naphthyridine derivative |
| 08/21/2013 | CN103261196A Pyrazolopyridines as inhibitors of the kinase lrrk2 |
| 08/21/2013 | CN103261195A 1,2,4-triazolo[4,3-]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 08/21/2013 | CN103261190A Novel benzofurane compounds |
| 08/21/2013 | CN103261189A Amino-pyrrolidine-zetidine diamides as monoacylglycerol lipase inhibitors |
| 08/21/2013 | CN103261163A Novel multicomponent crystals made of ([2-mino-6-(4-fluoro-benzylamino)- pyridin-3-yl]- carbamic acid ethyl ester and an arylpropionic acid |
| 08/21/2013 | CN103261162A Novel multicomponent crystals made of ([2-mino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid |
| 08/21/2013 | CN103261156A New compounds for the treatment of neurodegenerative diseases |
| 08/21/2013 | CN103260636A Therapeutic agent for disc herniation |
| 08/21/2013 | CN103260622A Novel fused pyridine compounds as casein kinase inhibitors |
| 08/21/2013 | CN103260619A Treatment of cognitive disorders with certain alpha- nicotinic acid receptor agonists in combination with acetylcholinesterase inhibitors |
| 08/21/2013 | CN103260616A Stabilizer of acetaminophen |
| 08/21/2013 | CN103260614A Combination therapy |
| 08/21/2013 | CN103260612A Treatment of mecp2-ssociated disorders |
| 08/21/2013 | CN103257189A (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use |